医药导报
醫藥導報
의약도보
HERALD OF MEDICINE
2001年
6期
341-342
,共2页
郑汉巧%董传仁%汪长华%李端详%欧阳静萍%涂淑珍%李柯
鄭漢巧%董傳仁%汪長華%李耑詳%歐暘靜萍%塗淑珍%李柯
정한교%동전인%왕장화%리단상%구양정평%도숙진%리가
血管紧张素Ⅱ%洛沙坦%PD123319%细胞增殖%一氧化氮合酶
血管緊張素Ⅱ%洛沙坦%PD123319%細胞增殖%一氧化氮閤酶
혈관긴장소Ⅱ%락사탄%PD123319%세포증식%일양화담합매
目的:利用血管紧张素Ⅱ受体拮抗药洛沙坦、PD123319研究血管紧张素Ⅱ2型受体对培养的大鼠主动脉平滑肌细胞增殖的影响。方法:将含有血管紧张素Ⅱ2型受体cDNA的质粒转染入培养的大鼠主动脉平滑肌细胞后,实验组分为血管紧张素Ⅱ处理组(组1)、血管紧张素Ⅱ和洛沙坦处理组(组2)、血管紧张素Ⅱ和PD123319处理组(组3)。检测核增殖抗原表达、细胞数目及一氧化氮合酶含量的变化。结果:组2细胞数目为(4.17±0.15)×105个,核增殖抗原平均光密度为0.202 6±0.007 6,较组3细胞明显减少(P<0.01);而组2细胞一氧化氮合酶平均光密度为0.027 5±0.002 1,明显高于组3细胞(0.016 9±0.002 0)(P<0.01)。结论:血管紧张素Ⅱ可能通过其2型受体表现为抑制血管平滑肌细胞增殖、拮抗1型受体的作用,血管紧张素Ⅱ2型受体的这种作用可能与增强一氧化氮合酶活性,使细胞合成、释放一氧化氮增多有关。
目的:利用血管緊張素Ⅱ受體拮抗藥洛沙坦、PD123319研究血管緊張素Ⅱ2型受體對培養的大鼠主動脈平滑肌細胞增殖的影響。方法:將含有血管緊張素Ⅱ2型受體cDNA的質粒轉染入培養的大鼠主動脈平滑肌細胞後,實驗組分為血管緊張素Ⅱ處理組(組1)、血管緊張素Ⅱ和洛沙坦處理組(組2)、血管緊張素Ⅱ和PD123319處理組(組3)。檢測覈增殖抗原錶達、細胞數目及一氧化氮閤酶含量的變化。結果:組2細胞數目為(4.17±0.15)×105箇,覈增殖抗原平均光密度為0.202 6±0.007 6,較組3細胞明顯減少(P<0.01);而組2細胞一氧化氮閤酶平均光密度為0.027 5±0.002 1,明顯高于組3細胞(0.016 9±0.002 0)(P<0.01)。結論:血管緊張素Ⅱ可能通過其2型受體錶現為抑製血管平滑肌細胞增殖、拮抗1型受體的作用,血管緊張素Ⅱ2型受體的這種作用可能與增彊一氧化氮閤酶活性,使細胞閤成、釋放一氧化氮增多有關。
목적:이용혈관긴장소Ⅱ수체길항약락사탄、PD123319연구혈관긴장소Ⅱ2형수체대배양적대서주동맥평활기세포증식적영향。방법:장함유혈관긴장소Ⅱ2형수체cDNA적질립전염입배양적대서주동맥평활기세포후,실험조분위혈관긴장소Ⅱ처리조(조1)、혈관긴장소Ⅱ화락사탄처리조(조2)、혈관긴장소Ⅱ화PD123319처리조(조3)。검측핵증식항원표체、세포수목급일양화담합매함량적변화。결과:조2세포수목위(4.17±0.15)×105개,핵증식항원평균광밀도위0.202 6±0.007 6,교조3세포명현감소(P<0.01);이조2세포일양화담합매평균광밀도위0.027 5±0.002 1,명현고우조3세포(0.016 9±0.002 0)(P<0.01)。결론:혈관긴장소Ⅱ가능통과기2형수체표현위억제혈관평활기세포증식、길항1형수체적작용,혈관긴장소Ⅱ2형수체적저충작용가능여증강일양화담합매활성,사세포합성、석방일양화담증다유관。
Objective:To observe the affection of angiotensin Ⅱ antagonists on the cultured subtype 2 receptor of angiotensin II transfected aortic vascular smooth muscle cells of rat.Methods:After transfected the plasmid that contained the cDNA of subtype 2 receptor of angiotensin II into cultured rat vascular smooth muscle cells, the cells were divided into three groups:cells of group 1 were treated with angiotensinⅡ,cells of group 2 were treated with angiotensinⅡand losartan,cells of group 3 were treated with angiotensinⅡ and PD123319 .After experiments,the expression of PCNA, NOS and the cell number was tested, respectively.Results:After treated with Losartan,the cell number of group 2 was(4.17±0.15)×105,the OD value of PCNA was 0.202 6±0.007 6,both of which were less than that of cells of group 3;the OD value of NOS of cells was more in group 2(0.027 5±0.002 1 ) than that in group 3 (0.016 9±0.002 0) (P<0.01).Conclusions:It suggests that when being activated,subtype 2 receptor of angiotensin Ⅱ could inhibit the proliferation of vascular smooth muscle cells and antagonist the effect of subtype 1 receptor of angiotensin Ⅱ,such an effect may be related to the activation of NOS.